Archived Reports

(For full reports click the company logo)

Epigenomics AG

June 17, 2020

We believe there is tremendous upside for investors by owning Epigenomics ahead of, what we expect to be, a positive CMS reimbursement decision by August 28th.

Essa Pharma

Nov 11, 2019

We believe
Big Pharma's familiarity with AR antagonism makes Essa a legitimate M&A candidate.

Acasti Pharma

November 25, 2019

We are initiating on Acasti Pharma as a high risk investment ideas.